cisapride has been researched along with Esophagitis in 11 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Esophagitis: INFLAMMATION, acute or chronic, of the ESOPHAGUS caused by BACTERIA, chemicals, or TRAUMA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effect of cisapride, a selective 5-hydroxytryptamine-4 receptor agonist, on the frequency of nocturnal transient lower oesophageal sphincter relaxations and oesophageal acid exposure in patients with gastro-oesophageal reflux disease." | 9.10 | Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study. ( McCallum, R; Olyaee, M; Pehlivanov, N; Sarosiek, I; Whitman, R, 2002) |
| "Following endoscopy 424 patients presenting with heartburn as the predominant symptom of gastro-oesophageal reflux disease were randomized to treatment with omeprazole 20 or 10 mg once daily, or cisapride 10 mg four times daily, in a double-blind, double-dummy, parallel group, multicentre study." | 9.08 | Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. ( Barthelemy, P; Galmiche, JP; Hamelin, B, 1997) |
| "In a double-blind, randomized, comparative trial of the prokinetic drug cisapride and the H2-blocker cimetidine, mucosal healing and changes in symptoms of gastroesophageal reflux were evaluated in patients with erosive reflux esophagitis." | 9.06 | Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. ( Evreux, M; Filoche, B; Fournet, J; Fraitag, B; Galmiche, JP; Soule, JC; Vitaux, J; Zeitoun, P, 1990) |
| "To investigate the effect of cisapride, a selective 5-hydroxytryptamine-4 receptor agonist, on the frequency of nocturnal transient lower oesophageal sphincter relaxations and oesophageal acid exposure in patients with gastro-oesophageal reflux disease." | 5.10 | Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study. ( McCallum, R; Olyaee, M; Pehlivanov, N; Sarosiek, I; Whitman, R, 2002) |
| "Following endoscopy 424 patients presenting with heartburn as the predominant symptom of gastro-oesophageal reflux disease were randomized to treatment with omeprazole 20 or 10 mg once daily, or cisapride 10 mg four times daily, in a double-blind, double-dummy, parallel group, multicentre study." | 5.08 | Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. ( Barthelemy, P; Galmiche, JP; Hamelin, B, 1997) |
| "In a double-blind, randomized, comparative trial of the prokinetic drug cisapride and the H2-blocker cimetidine, mucosal healing and changes in symptoms of gastroesophageal reflux were evaluated in patients with erosive reflux esophagitis." | 5.06 | Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis. ( Evreux, M; Filoche, B; Fournet, J; Fraitag, B; Galmiche, JP; Soule, JC; Vitaux, J; Zeitoun, P, 1990) |
| "Gastroesophageal reflux (GER) may aggravate chronic bronchopulmonary diseases." | 1.31 | Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis. ( Brodzicki, J; Korzon, M; Trawińska-Bartnicka, M, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodzicki, J | 1 |
| Trawińska-Bartnicka, M | 1 |
| Korzon, M | 1 |
| Lindahl, H | 1 |
| Rintala, R | 1 |
| Vandenplas, Y | 1 |
| Ashkenazi, A | 1 |
| Belli, D | 1 |
| Boige, N | 1 |
| Bouquet, J | 1 |
| Cadranel, S | 1 |
| Cezard, JP | 1 |
| Cucchiara, S | 1 |
| Dupont, C | 1 |
| Geboes, K | 1 |
| Dieckmann, K | 1 |
| Maurage, C | 1 |
| Rolland, JC | 1 |
| Ramponi, N | 1 |
| Jonville, AP | 1 |
| Galmiche, JP | 3 |
| Barthelemy, P | 1 |
| Hamelin, B | 1 |
| Pehlivanov, N | 1 |
| Sarosiek, I | 1 |
| Whitman, R | 1 |
| Olyaee, M | 1 |
| McCallum, R | 1 |
| Denié, C | 1 |
| Gohy, P | 1 |
| Allen, ML | 1 |
| McIntosh, DL | 1 |
| Robinson, MG | 1 |
| Fraitag, B | 2 |
| Filoche, B | 1 |
| Evreux, M | 1 |
| Vitaux, J | 1 |
| Zeitoun, P | 1 |
| Fournet, J | 1 |
| Soule, JC | 1 |
| Cloarec, D | 1 |
2 reviews available for cisapride and Esophagitis
| Article | Year |
|---|---|
A proposition for the diagnosis and treatment of gastro-oesophageal reflux disease in children: a report from a working group on gastro-oesophageal reflux disease. Working Group of the European Society of Paediatric Gastro-enterology and Nutrition (ESPGAN
Topics: Child; Child Nutritional Physiological Phenomena; Cisapride; Esophagitis; Esophagoscopy; Esophagus; | 1993 |
[Cisapride: pharmacology, current therapeutic results and future prospects].
Topics: Cisapride; Constipation; Dyspepsia; Esophagitis; Esophagus; Forecasting; Gastric Emptying; Gastroeso | 1989 |
3 trials available for cisapride and Esophagitis
| Article | Year |
|---|---|
Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.
Topics: Adult; Anti-Ulcer Agents; Cisapride; Double-Blind Method; Enzyme Inhibitors; Esophagitis; Female; Ga | 1997 |
Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
Topics: Cisapride; Cross-Over Studies; Double-Blind Method; Esophagitis; Esophagogastric Junction; Female; G | 2002 |
Double-blind comparison of cisapride and cimetidine in treatment of reflux esophagitis.
Topics: Adult; Cimetidine; Cisapride; Double-Blind Method; Drug Evaluation; Esophagitis; Esophagoscopy; Fema | 1990 |
6 other studies available for cisapride and Esophagitis
| Article | Year |
|---|---|
Frequency, consequences and pharmacological treatment of gastroesophageal reflux in children with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Child; Child, Preschool; Cisapride; Cystic Fibrosis; Endoscopy | 2002 |
Long-term complications in cases of isolated esophageal atresia treated with esophageal anastomosis.
Topics: Anastomosis, Surgical; Anti-Ulcer Agents; Cisapride; Constriction, Pathologic; Endoscopy, Digestive | 1995 |
Torticollis as a side effect of cisapride treatment in an infant.
Topics: Cisapride; Esophagitis; Female; Humans; Infant; Piperidines; Torticollis; Trimebutine | 1996 |
[Current indications for cisapride].
Topics: Cisapride; Esophagitis; Gastroesophageal Reflux; Gastrointestinal Agents; Humans | 2001 |
[Cytolytic hepatitis induced by cisapride].
Topics: Aged; Chemical and Drug Induced Liver Injury; Cisapride; Esophagitis; Humans; Male; Piperidines; Ser | 1992 |
Healing or amelioration of esophagitis does not result in increased lower esophageal sphincter or esophageal contractile pressure.
Topics: Adult; Aged; Cisapride; Esophageal Motility Disorders; Esophagitis; Esophagogastric Junction; Esopha | 1990 |